BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 22931983)

  • 1. TGF‑β1 induces CREB1‑mediated miR‑1290 upregulation to antagonize lung fibrosis via Napsin A.
    Guan S; Wu Y; Zhang Q; Zhou J
    Int J Mol Med; 2020 Jul; 46(1):141-148. PubMed ID: 32319530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Napsin A resensitizes drug-resistant lung cancer A549 cells to gefitinib by inhibiting EMT.
    Zhou L; Lv X; Yang J; Zhu Y; Wang Z; Xu T
    Oncol Lett; 2018 Aug; 16(2):2533-2538. PubMed ID: 30008942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Napsin A as a marker of clear cell ovarian carcinoma.
    Skirnisdottir I; Bjersand K; Akerud H; Seidal T
    BMC Cancer; 2013 Nov; 13():524. PubMed ID: 24191930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition].
    Xu GP; Li QQ; Cao XX; Chen Q; Zhao ZH; Diao ZQ; Xu ZD
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1918-23. PubMed ID: 17923018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
    Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-to-mesenchymal transition in fibrosis: collagen type I expression is highly upregulated after EMT, but does not contribute to collagen deposition.
    Hosper NA; van den Berg PP; de Rond S; Popa ER; Wilmer MJ; Masereeuw R; Bank RA
    Exp Cell Res; 2013 Nov; 319(19):3000-9. PubMed ID: 23906925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Napsin A is negatively associated with EMT‑mediated EGFR‑TKI resistance in lung cancer cells.
    Zhou L; Lv X; Yang J; Zhu Y; Wang Z; Xu T
    Mol Med Rep; 2018 Aug; 18(2):1247-1252. PubMed ID: 29845258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of epithelial-mesenchymal transition in A549 cell by transfected Napsin A.
    Zheng JX; Guan SH; Xu Q; Liu JZ; Song P
    Chin Med J (Engl); 2012 Aug; 125(15):2734-40. PubMed ID: 22931983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition.
    Imamichi Y; Menke A
    Cells Tissues Organs; 2007; 185(1-3):180-90. PubMed ID: 17587824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epithelial-mesenchymal transition in hepatocellular carcinoma].
    Sun B; Yin ZF
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):721-4. PubMed ID: 23291062
    [No Abstract]   [Full Text] [Related]  

  • 12. Early events in cell adhesion and polarity during epithelial-mesenchymal transition.
    Huang RY; Guilford P; Thiery JP
    J Cell Sci; 2012 Oct; 125(Pt 19):4417-22. PubMed ID: 23165231
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.